Barclays PLC Applied Therapeutics Inc. Transaction History

Barclays PLC

$288 Billion
Q1 2024

A detailed history of Barclays PLC transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Barclays PLC holds 61,272 shares of APLT stock, worth $262,244. This represents 0.0% of its overall portfolio holdings.

Number of Shares

61,272

Holding current value

$262,244

% of portfolio

0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$2.25 - $7.4 $137,862 - $453,412	61,272 New	61,272 $417,000
Q2 2023 Aug 03, 2023	BUY	$0.77 - $1.8 $170 - $397	221 Added 2009.09%	232 $0
Q1 2023 May 04, 2023	BUY	$0.75 - $1.21 $8 - $13	11 New	11 $0
Q2 2022 Aug 12, 2022	SELL	$0.76 - $2.64 $3,030 - $10,525	-3,987 Reduced 99.97%	1 $0
Q1 2022 May 16, 2022	SELL	$1.48 - $6.22 $25,914 - $108,912	-17,510 Reduced 81.45%	3,988 $8,000

Q4 2021 Feb 14, 2022	BUY	$8.77 - $18.29 $31,414 - $65,514	3,582 Added 19.99%	21,498 $193,000
Q3 2021 Nov 09, 2021	BUY	$13.54 - $22.06 $211,034 - $343,827	15,586 Added 668.93%	17,916 $298,000
Q2 2021 Aug 13, 2021	SELL	$14.05 - $25.04 $150,686 - $268,554	-10,725 Reduced 82.15%	2,330 $49,000
Q1 2021 May 13, 2021	BUY	$16.57 - $28.65 $143,463 - $248,051	8,658 Added 196.91%	13,055 $244,000
Q4 2020 Feb 11, 2021	SELL	$15.44 - $24.23 $28,394 - $44,558	-1,839 Reduced 29.49%	4,397 $97,000
Q3 2020 Nov 12, 2020	SELL	$19.43 - $35.36 $192,104 - $349,604	-9,887 Reduced 61.32%	6,236 $129,000
Q2 2020 Aug 12, 2020	SELL	$29.41 - $51.23 $254,396 - $443,139	-8,650 Reduced 34.92%	16,123 $584,000
Q1 2020 May 13, 2020	BUY	$19.54 - $55.47 $64,638 - $183,494	3,308 Added 15.41%	24,773 $810,000
Q4 2019 Feb 10, 2020	BUY	$10.16 - $28.14 $207,975 - $576,025	20,470 Added 2057.29%	21,465 $586,000
Q3 2019 Nov 14, 2019	BUY	$8.08 - $10.99 $8,039 - $10,935	995 New	995 $11,000

Others Institutions Holding APLT

# of Institutions

100

Shares Held

94M

Call Options Held

5.83M

Put Options Held

231K

Franklin Resources Inc San Mateo, CA

10.6M
Shares

$45.2 Million
0.02% of portfolio
Vr Adviser, LLC New York, NY

9.08M
Shares

$38.8 Million
5.3% of portfolio
Perceptive Advisors LLC New York, NY

8.01M
Shares

$34.3 Million
1.14% of portfolio
Janus Henderson Group PLC London, X0

6.41M
Shares

$27.5 Million
0.02% of portfolio
Propel Bio Management, LLC Los Angeles, CA

6.11M
Shares

$26.2 Million
24.19% of portfolio

View Full List

About Applied Therapeutics Inc.

Ticker APLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,700
Market Cap $206M
Description
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...

More about APLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account